Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	11.89B -21.8%
Revenue (ttm)	2.42B +1.8%
Net Income	667.92M +19.2%
EPS	1.21 +14.5%
Shares Out	566.88M
PE Ratio	17.35
Forward PE	n/a
Dividend	0.38 (1.81%)
Ex-Dividend Date	Jun 17, 2026

Volume	2,454,252
Open	20.35
Previous Close	20.90
Day's Range	20.35 - 21.04
52-Week Range	18.33 - 38.16
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral Tibetan and traditional Chinese medicine products, external analgesics, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,203
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2025, SHE:002287's revenue was 2.42 billion, an increase of 3.34% compared to the previous year's 2.34 billion. Earnings were 648.43 million, an increase of 11.36%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error